Kyowa Hakko Kirin | 4151 - Ebit

Aktienkurs
2,394.00
Täglich Wechseln
32.00 1.35%
Monatlich
-9.03%
Jährlich
9.27%
Q2 Prognose
2,260.03




Ebit Veränderung Datum
Astellas Pharma JPY 48.57B 85.97B 2026-03
Chugai Pharma JPY 158.77B 10.24B 2026-03
Daiichi Sankyo JPY 89.54B 42.01B 2025-12
Eisai JPY 20.03B 6.36B 2025-12
Kyowa Hakko Kirin JPY 38.35B 12.49B 2025-12
M3 JPY 10.65B 15.37B 2026-03
Otsuka Holdings JPY 118.21B 50.97B 2026-03
Shionogi JPY 73.97B 34.3B 2025-12
Sumitomo Dainippon JPY 75.66B 54.63B 2025-09
Takeda JPY 257.49B 568.56B 2025-12
Terumo JPY 43.88B 1.21B 2025-12